- Home
- NWL vs CPRX Comparison
NWL vs CPRX Comparison
Compare NWL & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWL
- CPRX
- Stock Information
- Founded
- NWL 1903
- CPRX 2002
- Country
- NWL United States
- CPRX United States
- Employees
- NWL N/A
- CPRX N/A
- Industry
- NWL Plastic Products
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- NWL Industrials
- CPRX Health Care
- Exchange
- NWL Nasdaq
- CPRX Nasdaq
- Market Cap
- NWL N/A
- CPRX 2.9B
- IPO Year
- NWL N/A
- CPRX 2006
- Fundamental
- Price
- NWL $5.26
- CPRX $22.76
- Analyst Decision
- NWL Buy
- CPRX Strong Buy
- Analyst Count
- NWL 9
- CPRX 7
- Target Price
- NWL $7.31
- CPRX $32.29
- AVG Volume (30 Days)
- NWL 9.6M
- CPRX 1.0M
- Earning Date
- NWL 04-30-2025
- CPRX 05-07-2025
- Dividend Yield
- NWL 5.60%
- CPRX N/A
- EPS Growth
- NWL N/A
- CPRX 178.13
- EPS
- NWL N/A
- CPRX 1.57
- Revenue
- NWL $7,495,000,000.00
- CPRX $534,645,999.00
- Revenue This Year
- NWL N/A
- CPRX $15.59
- Revenue Next Year
- NWL $1.60
- CPRX $8.90
- P/E Ratio
- NWL N/A
- CPRX $14.51
- Revenue Growth
- NWL N/A
- CPRX 29.97
- 52 Week Low
- NWL $4.22
- CPRX $14.47
- 52 Week High
- NWL $11.78
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- NWL 49.97
- CPRX 46.01
- Support Level
- NWL $4.92
- CPRX $22.94
- Resistance Level
- NWL $5.40
- CPRX $25.01
- Average True Range (ATR)
- NWL 0.27
- CPRX 0.83
- MACD
- NWL 0.10
- CPRX -0.05
- Stochastic Oscillator
- NWL 85.57
- CPRX 46.56
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).